Close Menu

Linda Avey from 23andMe appeared on CNBC's Healthy Horizons to discuss her company. The host asks Avey what she would say to critics who say the diseases arise from complex interactions of genes and environment and that what 23andMe provides is a small amount of information that could be misinterpreted. Avey replies: "We think that's poppycock. We think we should really be able to engage people directly."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Nature News reports that researchers in Japan hope to soon test the use of reprogrammed stem cells to treat damaged corneas.

A new approach may help limit the number of fish that are mislabeled at markets or restaurants, according to New Scientist.

At Slate, the R Street Institute's Nila Bala discusses the privacy rights of suspects that genetic genealogy approaches in law enforcement bring up.

In PNAS this week: numerous mobile genetic elements contribute to Vibrio cholerae drug resistance, troponin I mutations in sudden infant deaths, and more.